APA (7th ed.) Citation

Anastasiou, D., Cassino, C., & Schuch, R. (2019). 711. Exebacase (Lysin CF-301) Activity Against Staphylococcus aureus (S. aureus) Isolates From Bacteremic Patients Enrolled in a Phase 2 Study (CF-301-102). Open forum infectious diseases, 6(Supplement_2), S320. https://doi.org/10.1093/ofid/ofz360.779

Chicago Style (17th ed.) Citation

Anastasiou, Diane, Cara Cassino, and Raymond Schuch. "711. Exebacase (Lysin CF-301) Activity Against Staphylococcus Aureus (S. Aureus) Isolates From Bacteremic Patients Enrolled in a Phase 2 Study (CF-301-102)." Open Forum Infectious Diseases 6, no. Supplement_2 (2019): S320. https://doi.org/10.1093/ofid/ofz360.779.

MLA (9th ed.) Citation

Anastasiou, Diane, et al. "711. Exebacase (Lysin CF-301) Activity Against Staphylococcus Aureus (S. Aureus) Isolates From Bacteremic Patients Enrolled in a Phase 2 Study (CF-301-102)." Open Forum Infectious Diseases, vol. 6, no. Supplement_2, 2019, p. S320, https://doi.org/10.1093/ofid/ofz360.779.